Fidelity Investments
DCOY icon

Fidelity Investments’s Decoy Therapeutics DCOY Stock Holding History

Fidelity Investments’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– -$4 – 5608
2024
Q1 		– Hold
0
– – – 5311
2023
Q4 		– Hold
0
– – – 5206
2023
Q3 		– Hold
0
– – – 5003
2023
Q2 		– Hold
0
– – – 5353
2023
Q1 		– Hold
0
– – – 4916
2021
Q3 		– Hold
0
– – – 4963
2021
Q2 		– Hold
0
– – – 4811
2019
Q1 		– Hold
0
– – – 4152
2018
Q4 		– Hold
0
– – – 4091
2018
Q3 		– Hold
0
– – – 3776
2017
Q4 		– Hold
0
– -$742K – 2692
2017
Q3 		– Hold
0
– – – 2443
2017
Q2 		– Hold
0
– – – 2451
2017
Q1 		– Hold
0
– – – 2437
2016
Q4 		– Hold
0
– – – 2435
2016
Q3 		– Hold
0
– – – 2296
2016
Q2 		– Hold
0
– – – 2332
2016
Q1 		– Sell
-1
Closed -$8.04M – 2306
2015
Q4 		$7.48M Hold
1
– – ﹤0.01% 2082
2015
Q3 		$7.36M Hold
1
– – ﹤0.01% 2056
2015
Q2 		$10.5M Hold
1
– – ﹤0.01% 1993
2015
Q1 		$12M Buy
+1
New +$15.5M ﹤0.01% 1931

Other funds holding DCOY

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelity Investments's DCOY Position: Q2 2024 in Review

Fidelity Investments held its Decoy Therapeutics (DCOY) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5608.

Fidelity Investments first reported a position in DCOY in Q1 2015 and has held it in 4 quarters since. The position peaked at $12M in Q1 2015. 3 funds tracked by Wall St. Rank hold DCOY as of Q2 2024.

  • Fidelity Investments held 0 shares of Decoy Therapeutics worth $0 as of Q2 2024.
  • Fidelity Investments left its Decoy Therapeutics share count unchanged in Q2 2024.
  • Decoy Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2024, its #5608 holding.
  • Fidelity Investments first reported a position in Decoy Therapeutics in Q1 2015 and has held it in 4 quarters since.
  • Fidelity Investments's Decoy Therapeutics position peaked at $12M in Q1 2015.
  • 3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2024.

Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.